BioSpace News Archive

Business

PhoreMost Will Use Screening Platform to Boost Otsuka’s Gene Therapy Program

PhoreMost and Otsuka Pharmaceutical Co. entered into a multi-project collaboration to seek out disease-relevant pathways that can be exploited for the development of gene therapies to treat different illnesses.

January 21, 2020
·
2 min read
·
Alex Keown
Genetown

Almost 50 Non-Oncology Drugs Found to Kill Cancer Cells

Scientists at the Broad Institute of MIT and Harvard tested about 4,518 drugs on 578 human cancer cell lines. They discovered that almost 50 had previously unrecognized anti-cancer properties.

January 21, 2020
·
3 min read
·
Mark Terry
Drug Development

Is Alzheimer’s Type 3 Diabetes? Novo Nordisk is Willing to Find Out

Novo Nordisk specializes in the diabetes market. The company appears to be making an entry into the Alzheimer’s market, which isn’t as unusual or unexpected as it initially sounds.

January 21, 2020
·
3 min read
·
Mark Terry
Deals

Evotec SE: Increase of profitability guidance for financial year 2019

Evotec SE announced an increase in its profitability guidance for the financial year 2019 after the preliminary completion of the latest evaluation of the Company’s financial performance.

January 21, 2020
·
1 min read
Business

Sensyne Health Interim Results

Sensyne Health plc, the British Clinical AI technology company, announces its Interim Results for the 6 months ended 31 October 2019.

January 21, 2020
·
3 min read
Sensyne Health Study Shows Heart Failure Patients Benefit from Anticoagulants

A U.K. study confirmed that the use of blood-thinning medications benefits all heart failure patients, regardless of whether or not those patients have been diagnosed with atrial fibrillation.

January 21, 2020
·
2 min read
·
Alex Keown
Job Trends

After $12 Million in Incentives, Eli Lilly Adding 462 Jobs in North Carolina

The positions will be in manufacturing, assembly and packaging. The NC Department of Commerce approved the incentives this morning.

January 21, 2020
·
3 min read
·
Mark Terry
Deals

HepaRegeniX GmbH Secures Series B Financing in Excess of €11 Mio. to Advance First Drug Candidate to the Clinic

Preclinical data demonstrate efficacy of MKK4 inhibitors in liver regeneration and experimental acute and chronic liver disease models

January 21, 2020
·
2 min read
Biotech Bay

Landmark Nature Publication Demonstrates the Power of the Fluidigm Hyperion Imaging System to Identify Novel Cellular Signatures That Correlate with Distinct Clinical Outcomes

Retrospective Clinical Study Uses Highly Multiplexed Imaging Mass Cytometry to Reveal Previously Unknown Features of the Tumor Microenvironment and Novel Breast Cancer Subgroups

January 21, 2020
·
6 min read
Policy

Pharming receives EMA approval of new facility for expansion of RUCONEST® production

Pharming Group N.V. announced it has received European Medicines Agency approval of a Type II Variation for a new production facility for the Company’s lead product, RUCONEST®.

January 21, 2020
·
4 min read